The prognostic value of the pretreatment lung immune prognostic index in patients with metastatic hormone-sensitive and castration-resistant prostate cancer
- DOI
- 10.21037/atm-22-4318
- Published
- 2023-03
- Container
- Annals of Translational Medicine
- Publisher
- AME Publishing Company
- Open access
- unknown
Credibility signals
serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.21037/atm-22-4318,
title = {The prognostic value of the pretreatment lung immune prognostic index in patients with metastatic hormone-sensitive and castration-resistant prostate cancer},
author = {Zhipeng Wang and Haoyang Liu and Jinge Zhao and Junru Chen and Sha Zhu and Jindong Dai and Yuchao Ni and Nanwei Xu and Fengnian Zhao and Ben He and Xingming Zhang and Jiayu Liang and Guangxi Sun and Zhenhua Liu and Pengfei Shen and Hao Zeng},
year = {2023},
journal = {Annals of Translational Medicine},
doi = {10.21037/atm-22-4318},
url = {https://doi.org/10.21037/atm-22-4318}
}RIS
TY - JOUR TI - The prognostic value of the pretreatment lung immune prognostic index in patients with metastatic hormone-sensitive and castration-resistant prostate cancer AU - Zhipeng Wang AU - Haoyang Liu AU - Jinge Zhao AU - Junru Chen AU - Sha Zhu AU - Jindong Dai AU - Yuchao Ni AU - Nanwei Xu AU - Fengnian Zhao AU - Ben He AU - Xingming Zhang AU - Jiayu Liang AU - Guangxi Sun AU - Zhenhua Liu AU - Pengfei Shen AU - Hao Zeng PY - 2023 JO - Annals of Translational Medicine DO - 10.21037/atm-22-4318 UR - https://doi.org/10.21037/atm-22-4318 ER -
APA
Wang, Z., Liu, H., Zhao, J., Chen, J., Zhu, S., Dai, J., Ni, Y., Xu, N., Zhao, F., He, B., Zhang, X., Liang, J., Sun, G., Liu, Z., Shen, P., & Zeng, H. (2023). The prognostic value of the pretreatment lung immune prognostic index in patients with metastatic hormone-sensitive and castration-resistant prostate cancer. Annals of Translational Medicine. https://doi.org/10.21037/atm-22-4318
Source records
- crossref · retrieved 2026-09-25T07:21:00.673Z